• Discussion on the POINT trial (with Marc Fisher and Greg Albers)

  • Mar 2 2021
  • Durée: 18 min
  • Podcast

Discussion on the POINT trial (with Marc Fisher and Greg Albers)

  • Résumé

  • Professor Marc Fisher and Dr Greg Albers discuss the POINT trial, also commenting on when to consider ticagrelor versus clopidogrel.

    This programme is made possible thanks to an independent educational grant from AstraZeneca.

    Find more information at https://ime.springerhealthcare.com/programs/emerging-dual-anti-platelet-therapy-strategies-for-neurologists-in-secondary-stroke-prevention/

    Voir plus Voir moins

Ce que les auditeurs disent de Discussion on the POINT trial (with Marc Fisher and Greg Albers)

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.